Walker, Kyle J.
Williams, Christopher T.
Oladepo, Folasade O.
Lucas, John
Malone, David
Paine, Mark J. I.
Ismail, Hanafy M.
Funding for this research was provided by:
The Innovative Vector Control Consortium who are supported by the Bill and Melinda Gates Foundation, under grant number (OPP1148615, OPP1148615)
iiCON “Delivering Integrated Solutions for Human Infections” who are supported by UKRI SIPF Wave 1, under Ref number (107136)
Article History
Received: 22 December 2021
Accepted: 27 May 2022
First Online: 11 June 2022
Competing interests
: John Lucas was an employee of Sumitomo Chemical (UK) plc at the time this work was conducted. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.